As Insmed Incorporated (INSM) Shares Declined, Shareholder Foresite Capital Management Ii LLC Increased Stake by $6.78 Million

April 20, 2018 - By Andre Harris

Insmed Incorporated (NASDAQ:INSM) Corporate LogoDuring Q4 2017 the big money sentiment decreased to 1. That’s change of 2.74, from 2017Q3’s 3.74. 27 investors sold all, 40 reduced holdings as INSM ratio fall. 49 grew positions while 18 funds acquired positions. Funds hold 73.21 million shares thus 49.25% less from 2017Q3’s 144.25 million shares. Emerald Advisers Pa accumulated 859,011 shs or 1.03% of the stock. 260,795 are owned by Td Asset Mgmt. Moreover, Wells Fargo Com Mn has 0% invested in Insmed Incorporated (NASDAQ:INSM) for 43,763 shs. Us Fincl Bank De has 0% invested in Insmed Incorporated (NASDAQ:INSM) for 1,413 shs. Voya Inv Mngmt Limited Liability Com invested in 0.04% or 683,139 shs. Parametric Portfolio Assocs Ltd Co reported 60,585 shs or 0% of all its holdings. Proshare Advsr Lc holds 52,620 shs. Moreover, Gemmer Asset Ltd Co has 0% invested in Insmed Incorporated (NASDAQ:INSM) for 3 shs. Qs Investors Ltd Limited Liability Company reported 0.02% stake. Clearbridge Investments Ltd Liability Com invested in 1,376 shs or 0% of the stock. International Gp Incorporated holds 51,539 shs or 0.01% of its capital. 691,982 are held by Geode Mngmt Ltd Llc. Jane Street Ltd Co invested in 11,916 shs or 0% of the stock. Blackrock Inc has invested 0.01% of its capital in Insmed Incorporated (NASDAQ:INSM). California Pub Employees Retirement Sys invested in 0% or 86,600 shs.

The stake In Insmed Incorporated (INSM) was upped held by Jim Tanenbaum. According to 2017Q4 Securities and Exchange filling the decrease is 72.88%. The company’s stock sank 30.16% while Foresite Capital Management Ii Llc bought 218,645 shares. At the end of 2017Q4, the hedge fund run by Jim Tanenbaum held 518,645 shares of the health care company, valued at $16.17M, up from 300,000 at the end of the previous reported quarter. Insmed Incorporated has $1.77B market cap. Ticker’s shares touched $23.11 during the last trading session after 2.16% change.Insmed Incorporated has volume of 595,978 shares. Since April 20, 2017 INSM has risen 31.10% and is uptrending. The stock outperformed the S&P 500 by 19.55%.

Foresite Capital Management Ii Llc has cut its stake in and also reduced its holding in by shares in the quarter, for a total of shares.

Insmed Incorporated (NASDAQ:INSM) Ratings Coverage

Total analysts of 5 have positions in Insmed (NASDAQ:INSM) as follows: 5 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. The firm has $43.0 highest while $32.0 is the lowest target. The average target $39.60 is 71.35% above the last ($23.11) price. Since October 30, 2017 according to StockzIntelligence Inc Insmed has 8 analyst reports. The stock rating was maintained by Robert W. Baird with “Buy” on Monday, October 30. On Wednesday, March 14 the firm has “Buy” rating given by Leerink Swann. In Thursday, January 4 report Robert W. Baird maintained the stock with “Buy” rating. On Thursday, January 4 the rating was upgraded by Stifel Nicolaus to “Buy”. On Thursday, January 4 the firm earned “Buy” rating by H.C. Wainwright. On Thursday, November 2 the firm has “Buy” rating by Stifel Nicolaus given. On Monday, November 6 the firm earned “Buy” rating by H.C. Wainwright.

Insmed Incorporated (NASDAQ:INSM) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.